RA Capital Management - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 80 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2022$2,071,000
-97.8%
1,726,019
-81.6%
0.06%
-96.0%
Q1 2021$92,347,000
-10.3%
9,365,833
-1.4%
1.39%
-3.3%
Q4 2020$103,006,000
+6.3%
9,502,383
+1.0%
1.44%
-18.8%
Q3 2020$96,932,000
-40.5%
9,410,860
+20.6%
1.77%
-44.1%
Q2 2020$162,898,000
+129.3%
7,801,641
+7.3%
3.17%
+41.4%
Q1 2020$71,054,0007,272,7142.24%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders